MIF and neoplasm: Another HSP90 client protein is the pleiotropic cytokine macrophage migration inhibitory factor (MIF), which is often elevated in cancer cells and correlates with tumor aggressiveness and poor prognosis.57 Curiously, PEITC covalently modifies MIF at its N‐terminal proline, P2, causing conformational changes which disrupt its catalytic tautomerase activity as well as its binding to other proteins.58